Emmaus Life Sciences CEO Willis C. Lee acquires 290,767 common shares worth $14,186.02

Reuters2026/09/02 19:06

By:Reuters

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Emmaus Life Sciences CEO Willis C. Lee reported open-market purchases of 460,767 common shares through a Fidelity Roth IRA.
Implied purchase prices ranged from USD 0.01 to USD 0.06 per share.
Roth IRA holdings rose to 690,167 shares; Lee also reported 395,124 shares held directly.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Emmaus Life Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-380023), on September 02, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Emmaus Life Sciences CEO Willis C. Lee acquires 290,767 common shares worth $14,186.02

You may also like

Crypto prices